UnitedHealth Group Just Hit a 52-Week High. Is It Too Late to Buy This Soaring Stock?
Written by Patrick Sanders for The Motley Fool -> Even after a big climb higher this year, UnitedHealth Group is still down more than 30% from where it traded in 2024. The company gets 44% of its business from Medicare and Medicaid. A year ago, UnitedHealth Group (NYSE: UNH) s
Even after a big climb higher this year, UnitedHealth Group is still down more than 30% from where it traded in 2024.
The company gets 44% of its business from Medicare and Medicaid.
A year ago, UnitedHealth Group (NYSE: UNH) stock was a disaster. It had fallen sharply after the company encountered higher-than-anticipated costs from its members, causing it to miss analysts' estimates for the first time since the 2008-09 financial crisis.
But today, UnitedHealth Group is trading near a 52-week high. The federal government has announced better-than-expected reimbursement rates for Medicare Advantage, margins have improved, and the stock has jumped 23% since the beginning of the year.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
But despite the rally, UnitedHealth Group stock remains down more than 34% from where it traded just two years ago. Does the stock have more room to run higher, or is this a good time for investors to take profits?
The company's failure to meet expectations in the first quarter of 2025 triggered the company's downturn, so a look at its recent performance is important.
Revenue was $111.72 billion, up 2% from a year ago -- but more importantly, it was better than the $109.57 billion analysts projected. Adjusted earnings per share came in at $7.23, versus analysts' expectations of $6.57.
